LTIP610A - Inhibitors of cells proliferation, pharmaceutical composition and method for preparation of compounds - Google Patents

Inhibitors of cells proliferation, pharmaceutical composition and method for preparation of compounds

Info

Publication number
LTIP610A
LTIP610A LTIP610A LTIP610A LTIP610A LT IP610 A LTIP610 A LT IP610A LT IP610 A LTIP610 A LT IP610A LT IP610 A LTIP610 A LT IP610A LT IP610 A LTIP610 A LT IP610A
Authority
LT
Lithuania
Prior art keywords
inhibitors
compounds
preparation
pharmaceutical composition
cells proliferation
Prior art date
Application number
LTIP610A
Inventor
Ole Didrik Laerum
Original Assignee
Hafslund Nycomed Bioreg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hafslund Nycomed Bioreg filed Critical Hafslund Nycomed Bioreg
Publication of LTIP610A publication Critical patent/LTIP610A/en
Publication of LT3714B publication Critical patent/LT3714B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4722—G-proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C07K7/067—Hemoregulatory peptides based on sequence Glp-Glu-Asp-Cys-Lys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Pentapeptides and derivatives thereof, including derivatives having one or more additional amino acids inserted in the sequence and/or added at the C- and N-termini, have been found to possess good activity in the inhibition of stem cell proliferation. In addition groups of novel peptides are disclosed, having improved and/or specifically directed inhibitory actions.
LTIP610A 1988-09-16 1993-06-03 Inhibitors of cells proliferation, pharmaceutical composition and method for preparation of compounds LT3714B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888821785A GB8821785D0 (en) 1988-09-16 1988-09-16 Peptide compounds

Publications (2)

Publication Number Publication Date
LTIP610A true LTIP610A (en) 1994-12-27
LT3714B LT3714B (en) 1996-02-26

Family

ID=10643722

Family Applications (1)

Application Number Title Priority Date Filing Date
LTIP610A LT3714B (en) 1988-09-16 1993-06-03 Inhibitors of cells proliferation, pharmaceutical composition and method for preparation of compounds

Country Status (22)

Country Link
US (1) US5484770A (en)
EP (2) EP0434718A1 (en)
JP (1) JPH04500666A (en)
KR (1) KR900701828A (en)
CN (1) CN1041159A (en)
AT (1) ATE110742T1 (en)
AU (1) AU641366B2 (en)
CA (1) CA1339947C (en)
DE (1) DE68917837T2 (en)
DK (1) DK39591D0 (en)
ES (1) ES2058479T3 (en)
GB (1) GB8821785D0 (en)
GE (1) GEP19971041B (en)
HU (2) HU895788D0 (en)
IE (1) IE64181B1 (en)
LT (1) LT3714B (en)
LV (1) LV10108B (en)
MY (1) MY104909A (en)
NZ (1) NZ230654A (en)
RU (1) RU2079509C1 (en)
WO (1) WO1990002753A1 (en)
ZA (1) ZA896980B (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5620957A (en) * 1989-07-14 1997-04-15 Smithkline Beecham Corporation Hemoregulatory peptides
HU206372B (en) * 1990-09-03 1992-10-28 Richter Gedeon Vegyeszet Process for producing new oligopeptides which selectively inhibit proliferation of haemopoietic cells and pharmaceutical compositions comprising same
HU206374B (en) * 1990-09-03 1992-10-28 Richter Gedeon Vegyeszet Process for producing pentapeptide and its salts specifically inhibiting proliferation of epidermic cells, as well as pharmaceutical compositions comprising same as active ingredient
TW222280B (en) * 1991-11-26 1994-04-11 Smithkline Beecham Corp
IL104323A0 (en) * 1992-01-10 1993-05-13 Smithkline Beecham Corp Hemoregulatory peptides
GB9211677D0 (en) 1992-06-02 1992-07-15 Nycomed Bioreg As Peptide compounds
GB9211674D0 (en) 1992-06-02 1992-07-15 Nycomed Bioreg As Peptide compounds
GB9211668D0 (en) * 1992-06-02 1992-07-15 Nycomed Bioreg As Peptide compounds
GR1001502B (en) * 1992-11-26 1994-02-28 Smithkline Beecham Corp Hemoregulatory peptides.
CN1034735C (en) * 1993-01-02 1997-04-30 史密丝克莱恩比彻姆公司 Hemoregulatory peptides
US5521284A (en) * 1994-08-01 1996-05-28 Arizona Board Of Regents Acting On Behalf Of Arizona State University Human cancer inhibitory pentapeptide amides and esters
US5504191A (en) * 1994-08-01 1996-04-02 Arizona Board Of Regents Acting On Behalf Of Arizona State University Human cancer inhibitory pentapeptide methyl esters
EP1070727A1 (en) * 1999-03-01 2001-01-24 Aventis Pharma Deutschland GmbH Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction
CN1403474A (en) * 2001-09-05 2003-03-19 中国人民解放军军事医学科学院生物工程研究所 Short peptide and medicine with short peptide as active component
WO2004009616A2 (en) * 2002-07-23 2004-01-29 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Ghrelin analogs

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA838780B (en) * 1982-11-26 1985-01-30 Nyegaard & Co As Peptide compounds
NO860752L (en) * 1985-06-26 1986-12-29 Bio Tech As PENTAPEPTIDES WITH CELL GROWTH REGULATORY EFFECTS AND PROCEDURES FOR PRODUCING THEREOF.
US4748154A (en) * 1985-12-24 1988-05-31 Takeda Chemical Industries, Ltd. Peptide derivatives, their production and use
GB8626539D0 (en) * 1986-11-06 1986-12-10 Nycomed As Peptide compounds

Also Published As

Publication number Publication date
LV10108B (en) 1994-10-20
LT3714B (en) 1996-02-26
EP0359338A1 (en) 1990-03-21
ES2058479T3 (en) 1994-11-01
HUT58765A (en) 1992-03-30
HU895788D0 (en) 1991-08-28
KR900701828A (en) 1990-12-04
IE892954L (en) 1990-03-16
US5484770A (en) 1996-01-16
MY104909A (en) 1994-06-30
DE68917837T2 (en) 1994-12-22
AU4218389A (en) 1990-04-02
LV10108A (en) 1994-05-10
JPH04500666A (en) 1992-02-06
RU2079509C1 (en) 1997-05-20
GB8821785D0 (en) 1988-10-19
ZA896980B (en) 1990-06-27
CA1339947C (en) 1998-07-07
ATE110742T1 (en) 1994-09-15
HU208027B (en) 1993-07-28
AU641366B2 (en) 1993-09-23
EP0434718A1 (en) 1991-07-03
EP0359338B1 (en) 1994-08-31
IE64181B1 (en) 1995-07-12
WO1990002753A1 (en) 1990-03-22
GEP19971041B (en) 1997-11-26
DE68917837D1 (en) 1994-10-06
DK39591A (en) 1991-03-06
NZ230654A (en) 1991-10-25
CN1041159A (en) 1990-04-11
DK39591D0 (en) 1991-03-06

Similar Documents

Publication Publication Date Title
IE881755L (en) Novel proteins with factor viii activity, process for their¹preparation using genetically engineered cells and¹pharmaceutical compositions containing them
LTIP610A (en) Inhibitors of cells proliferation, pharmaceutical composition and method for preparation of compounds
EP0220957A3 (en) Platelet binding inhibitors
CA2270289A1 (en) Proteins with enhanced levels of essential amino acids
BG103977A (en) Low molecular rotamase enzymic activity inhibitors
IE811275L (en) Vinblastines
MY110104A (en) Saccharin derivative proteolytic enzyme inhibitors
EP0151246A3 (en) Polypeptide inhibitor of the activity of alpha-amylase, process for its preparation, its use, and pharmaceutical preparations
ZA856466B (en) Amino acid derivatives as enzyme inhibitors
MY106202A (en) Saccharin derivatives useful as proteolytic enzyme inhibitors and preparation thereof.
NZ503235A (en) Amino-terminally truncated RANTES as chemokine antagonists
DK0572688T3 (en) Peptides, with organ-protective activity, method for their preparation and their use in therapy
AU1662188A (en) Amino acid 1,2-diketo derivatives as renin inhibitors
EP0225020A3 (en) Peptides comprising, in sequence, units selected from the amino-acid residues 17 to 24 of vip
AU1031697A (en) Novel geranylgeranyl-derivatives, process for the preparation thereof and related pharmaceutical compositions
IL126221A0 (en) Scf analog compositions and methods
EP0319315A3 (en) The von willebrand factor binding domain of factor viii
ES8900018A1 (en) Rennin- and acid proteases-inhibitor peptidic amino alcohol derivatives, preparation process thereof and therapeutical application thereof.
EP0333000A3 (en) Peptides with inhibitory activity of enzymatic systems, process for their preparation and pharmaceutical compositions containing them
WO1997014966B1 (en) Method of activating a novel ligand regulatory pathway
IE790619L (en) Psychopharmacological peptides
ES8204713A1 (en) A purified polypeptide, a process for its preparation, its use and pharmaceutical compositions containing it.
EP0332999A3 (en) Peptides with inhibitory activity of enzymatic systems, process for their preparation and pharmaceutical compositions containing them
DE3682368D1 (en) MITOGENIC PEPTIDES.
NO910981L (en) Peptide.

Legal Events

Date Code Title Description
PC9A Transfer of patents

Free format text: NYCOMED IMAGING AS,NYCOVEIEN 1-2, N-0401 OSLO 4,NO,19961106

PD9A Change of patent owner

Free format text: HAFSLUND ASA,SLEMDALSVEIEN 37, N-0301 OSLO 3,NO,19961106,

MM9A Lapsed patents

Effective date: 19980603